Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-03-Speech-4-437-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110203.25.4-437-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Vaccinating against TB and investing in research aimed at developing new treatments for this disease are the only solutions to eradicate it by 2050. Unfortunately, Romania has a poor record in terms of the spread of this disease, topping the league table for tuberculosis patients in the European Union, where it will remain for a long time, according to the experts. In these circumstances, the programmes run by the EU and finances allocated for TB treatment are especially welcome, and the investment in Europeans’ health is important. According to data from the Romanian authorities, 30 000 new cases of tuberculosis appear in Romania every year. One possible explanation for detecting this large number of cases every year is precisely the increase in the level of progress through the emergence of new prevention programmes, the majority of which are funded by the EU. Although Romania still has the highest incidence of tuberculosis in Europe, the values for this indicator have seen a significant reduction in the last five years. There has also been a downward trend in the mortality figures recorded for tuberculosis in Romania, from 10.7% in 2002 to 7.6% in 2008. The funding granted to the TB eradication programmes is particularly welcome as no new diagnostic or treatment instruments have been discovered in the last 35 years."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples